These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36117308)

  • 1. Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
    Yuan Z; Wang S; Ni K; Zhan Y; Ma H; Liu X; Xin R; Zhou X; Liu Z; Zhao X; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Cui W; Zhang X; Zhang Q; Zhang C
    Med Sci Monit; 2022 Sep; 28():e937757. PubMed ID: 36117308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
    Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
    Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
    Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
    BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
    Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
    PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chidharla A; Rapoport E; Agarwal K; Madala S; Linares B; Sun W; Chakrabarti S; Kasi A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor.
    Leerhoff S; Raem A; Kolbe EW; Schulz L; Borchers K; Köhler T; Winde G; Kirchner C
    Cancer Treat Res Commun; 2023; 36():100748. PubMed ID: 37541105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
    Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
    J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
    Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
    Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of serum methylated septin 9 and carcinoembryonic antigen in efficacy evaluation and follow-up monitoring of colorectal cancer.
    Gao H; Zhu ZQ; Wusiman L; Wujieke A; Zhang WB
    Ann Ital Chir; 2023; 94():384-391. PubMed ID: 37794798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Performance of Methylated
    Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
    Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
    [No Abstract]   [Full Text] [Related]  

  • 16. mSEPT9 Can Monitor the Response and Predict the Prognosis of Stage IV Colorectal Cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery.
    Liu W; Hu P; Liu J; Chen L
    J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
    Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylated Septin9 (m
    Loomans-Kropp HA; Song Y; Gala M; Parikh AR; Van Seventer EE; Alvarez R; Hitchins MP; Shoemaker RH; Umar A
    Cancer Res Commun; 2022 Feb; 2(2):90-98. PubMed ID: 35992328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
    Wang W; Zhu X; Zhang X; Lei C; Zeng Z; Lan X; Cui W; Wang F; Xu S; Zhou J; Wu X; Deng H; Li X; Fan J; Ding Y; Huang Z; Liang L
    J Pathol; 2023 Apr; 259(4):376-387. PubMed ID: 36573552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.